Hiv-1 gag

From Proteopedia

(Difference between revisions)
Jump to: navigation, search
Line 19: Line 19:
----
----
-
Once Gag is localized to discreet sites on the plasma membrane, multimerization of Gag takes place quite quickly , driven by the CA domain, and more specifically our focus here, the C-terminal domain of CA (CTD). There are four helices that contribute to the interaction of CA CTD with it's partner. <scene name='Hiv-1_gag/Cv/1'>A side-by-side interaction of CA CTD has been proposed </scene>, but many believe the forces involved in the side-by-side model are not great enough to account for the organization and structural stability of assembled Gag. Also, helix 1 of the CA CTD contains a very conserved region of residues within many retroviruses called the <scene name='User:Nathan_Roy/Mhr_side-by-side/1'>MHR (major homology region)</scene>. In the side-by-side model, the MHR is not responsible for the dimer organization, yet mutations in the MHR region have a greater impact on ''in vivo'' Gag assembly than mutations in the residues responsible for structural stablility of the side-by-side model. This led researchers to seek a domain swapped structure of the CA CTD. By making a single deletion of the Ala 177 residue (which lies in the loop between helix 1 and helix 2), the CA CTD domain adopts a domain-swapped conformation,<applet load='2ont_dimer.pdb' size='300' frame='true' align='right' caption='FIGURE 4. Domain swapped CA CTD, [[2ont]]' /> in which the MHR of helix 1 is extended to contact helices 2,3, and 4 of the adjacent CA CTD domain (Figure 4)(<scene name='User:Nathan_Roy/Mhr_domain_swapped/1'>MHR region</scene>). Keep in mind these are only models of Gag dimerization and subsequent multimerization, and that precise interactions that take place during Gag assembly are yet to be agreed upon.
+
Once Gag is localized to discreet sites on the plasma membrane, multimerization of Gag takes place quite quickly , driven by the CA domain, and more specifically our focus here, the C-terminal domain of CA (CTD). There are four helices that contribute to the interaction of CA CTD with it's partner. <scene name='Hiv-1_gag/Cv/1'>A side-by-side interaction of CA CTD has been proposed </scene>, but many believe the forces involved in the side-by-side model are not great enough to account for the organization and structural stability of assembled Gag. Also, helix 1 of the CA CTD contains a very conserved region of residues within many retroviruses called the <scene name='User:Nathan_Roy/Mhr_side-by-side/1'>MHR (major homology region)</scene>. In the side-by-side model, the MHR is not responsible for the dimer organization, yet mutations in the MHR region have a greater impact on ''in vivo'' Gag assembly than mutations in the residues responsible for structural stablility of the side-by-side model. This led researchers to seek a domain swapped structure of the CA CTD. By making a single deletion of the Ala 177 residue (which lies in the loop between helix 1 and helix 2), the <scene name='User:Nathan_Roy/Mhr_domain_swapped/1'>CA CTD domain adopts a domain-swapped conformation, in which the MHR of helix 1 is extended to contact helices 2,3, and 4 of the adjacent CA CTD domain</scene>. Keep in mind these are only models of Gag dimerization and subsequent multimerization, and that precise interactions that take place during Gag assembly are yet to be agreed upon.
-
 
+
Note the CA NTD was not discussed here. Through biochemical studies, the NTD domain has been implicated in viral capsid assembly, but reliable structural data giving biological insights has been elusive.
Note the CA NTD was not discussed here. Through biochemical studies, the NTD domain has been implicated in viral capsid assembly, but reliable structural data giving biological insights has been elusive.
- 
- 
- 
- 
- 
- 
- 
- 
- 
- 
- 
- 
- 
- 
- 
- 
- 
- 
- 
- 
==Nucleocapsid (NC)==
==Nucleocapsid (NC)==

Revision as of 10:08, 4 April 2013

PDB ID 2h3i

Drag the structure with the mouse to rotate

Proteopedia Page Contributors and Editors (what is this?)

Alexander Berchansky, Michal Harel, Nathan Roy

Personal tools